Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus

Molecular Brain Research

Volumn 49, Issue 1-2, 1997, Pages 283-290

  Connor, B ^a   Beilharz, E J ^b   Williams, C ^b   Synek, B ^b   Gluckman, P D ^b   Faull, R L M ^b   Dragunow, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

amyloid protein; Astrogliosis; Neurodegeneration; Neurotrophic factor; Senile plaque

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; SOMATOMEDIN C;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MACROGLIA; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; TEMPORAL CORTEX; TISSUE LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; ASTROCYTES; CROSS REACTIONS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEURONS; REFERENCE VALUES; TEMPORAL LOBE;

EID: 0030656250     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00192-7     Document Type: Article

References (57)

1. Anderson A.J., Sum J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719.
2. Araujo D.M., Cotman C.W. β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain. 569:1992;141-145.
3. Araujo D.M., Lapchak P.A., Robitaille Y., Gauthier S., Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of the human brain in Alzheimer's disease. J. Neurochem. 50:1988;1914-1923.
4. Arias C., Arrieta I., Tapia R. β-Amyloid peptide fragment 25-35 potentiates the calcium-dependent release of excitatory amino acids from depolarised hippocampal slices. J. Neurosci. Res. 41:1995;561-566.
5. Arkins S., Rebeiz N., Biragyn A., Reese D.L., Kelley K.W. Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology. 133:1993;2334-2343.
6. Baskin D.G., Wilcox B.J., Figlewicz D.P., Dorsa D.M. Insulin and insulin-like growth factors in the CNS. Trends Neurosci. 11:1988;107-111.
7. Behl C., Davis J.B., Klier F.G., Schubert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
8. Beilharz E.J., Klempt N.D., Klempt M., Sirimanne E., Dragunow M., Gluckman P.D. Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Mol. Brain Res. 18:1993;209-215.
9. Bondy C., Werner H., Roberts C.T., LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience. 46:1992;909-923.
10. Burgess S.K., Jacobs S., Cuatrecasa P., Sahyoun N. Characterization of a neuronal subtype of a insulin-like growth factor I receptor. J. Biol. Chem. 262:1987;1618-1622.
11. Cheng B., Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12:1992;1558-1566.
12. Connor B., Young D., Lawlor P., Gai W., Waldvogel H., Faull R.L.M., Dragunow M. Trk receptor alterations in Alzheimer's disease. Mol. Brain Res. 42:1996;1-17.
13. Cotman C.W., Anderson A.J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:1995;19-45.
14. Crews F.T., McElhaney R., Freund G., Ballinger W.E., Raizada M.K. Insulin-like growth factor I receptor binding in brains of Alzheimer's and alcoholic patients. J. Neurochem. 58:1992;1205-1210.
15. De Keyser J., Wilczak N., Goossen A. Insulin-like growth factor-I receptor densities in human frontal cortex and white matter during aging, in Alzheimer's disease, and in Huntington's disease. Neurosci. Lett. 172:1994;93-96.
16. DeLacoste M., White C.L. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol. Aging. 14:1993;1-16.
17. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C., Bravo R., Gluckman P. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to young rat brain. Mol. Brain Res. 25:1994;19-33.
18. Dragunow M., Faull R.L.M., Lawlor P., Beilharz E.J., Singleton K., Walker E.B., Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport. 6:1995;1053-1057.
19. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of β-amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
20. Frederickson R.C.A. Astroglia in Alzheimer's disease. Neurobiol. Aging. 13:1992;239-253.
21. Galli C., Meucci O., Scorziello A., Werge T.M., Calissano P., Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15:1995;1172-1179.
22. Gammeltoft S., Haselbacher G.K., Humbel R.E., Fehlmann M., Van Obberghen E. Two types of receptor for insulin-like growth factors in mammalian brain. EMBO J. 4:1985;3407-3412.
23. Garcia-Estrada J., Garcia-Segura L.M., Torres-Aleman I. Expression of insulin-like growth factor 1 by astrocytes in response to injury. Brain Res. 592:1992;343-347.
24. Garcia-Segura L.M., Perez J., Pons S., Rejas M.T., Torres-Aleman I. Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 560:1991;167-174.
25. Gluckman P.D., Guan J., Beilharz E.J., Klempt N.D., Klempt M., Miller O., Sirimanne E., Dragunow M., Williams C.E. The role of insulin-like growth factor system in neuronal rescue. Ann. NY Acad. Sci. 692:1993;138-148.
26. Gluckman P.D., Klempt N.D., Guan J., Mallard E.C., Sirimanne E., Dragunow M., Klempt M., Singh K., Williams C.E., Nikolics K. A role for IGF-I in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182:1992;593-599.
27. Granerus M., Schofield P., Bierke P., Engstrom W. Growth factors and apoptosis in development - the role of insulin-like growth factor I and TGF-beta-1 in regulating cell growth and cell death in a human teratocarcinoma-derived cell line. Int. J. Dev. Biol. 39:1995;759-764.
28. Guan J., Williams C.E., Gunning M., Mallard E.C., Gluckman P.D. The effects of IGF-I treatment after hypoxic-ischemic injury in adult rats. J. Cereb. Blood Flow Metab. 13:1993;609-616.
29. Harrigan M.R., Kunkel D.D., Nguyen L.B., Malouf A.T. β-Amyloid is neurotoxic in hippocampal slice cultures. Neurobiol. Aging. 16:1995;779-789.
30. Hoke A., Canning D.R., Malemud C.J., Silver J. Regional differences in reactive gliosis induced by substrate-bound β-amyloid. Exp. Neurol. 130:1994;56-66.
31. Hyman B.T., VanHoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1169.
32. Johnston B.M., Mallard E.C., Williams C.E., Gluckman P.D. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J. Clin. Invest. 97:1996;300-308.
33. Jung Y.K., Miura M., Yuan J.Y. Suppression of interleukin-1β-converting enzyme-mediated cell death by insulin-like growth factor. J. Biol. Chem. 271:1996;5112-5117.
34. 125I]insulin receptor binding sites in the rat hippocampal formation. Neuroscience. 55:1993;69-80.
35. Klempt N.D., Klempt M., Gunn A.J., Singh K., Gluckman P.D. Expression of insulin-like growth factor-binding protein 2 (IGF-BP2) following transcient hypoxia-ischemia in the infant rat brain. Mol. Brain Res. 15:1992;55-61.
36. Lee W.H., Clemens J.A., Bondy C.A. Insulin-like growth factors in the response to cerebral ischemia. Mol. Cell. Neurosci. 3:1992;36-43.
37. Lievre C.A.-L., Stahlbom P.-A., Sara V.R. Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development. 111:1991;105-115.
38. Mann D.M. Is the pattern of nerve cell loss in aging and Alzheimer's disease real, or only apparent, selectivity? Neurobiol. Aging. 12:1991;340-343.
39. Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., Rydel R.E. β-Amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
40. McDonald W.M., Nemeroff C.B. Neurotransmitters and neuropeptides in Alzheimer's disease. Psychiatric Clin. N. Am. 14:1991;421-435.
41. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., Van Belle G., Berg L. The Consortium to establish a registry for Alzheimer's disease (CERAD). Neurology. 41:1991;479-486.
42. Murphy G.M., Ellis W.G., Lee Y., Stultz K.E., Shrivastava R., Tinklenberg J.R., Eng L.F. Astrocytic gliosis in the amygdala in Downs syndrome and Alzheimer's disease. Prog. Brain Res. 94:1992;475-484.
43. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:1995;253-265.
44. Price D.L., Borchelt D.R., Walker L.C., Sisodia S.S. Toxicity of synthetic Aβ peptides and modeling of Alzheimer's disease. Neurobiol. Aging. 13:1992;623-625.
45. Quirion R., Araujo D.M., Lapchak P.A., Seto D., Chabot J.-G. Growth factors and lymphokines: modulators of cholinergic neurons activity. Can. J. Neurol. Sci. 18:1991;390-393.
46. Rom W.N., Basset P., Fells G.A., Nukiwa T., Trapnell B.C., Crystal R.G. Alveolar macrophages release an insulin-like growth factor I-type molecule. J. Clin. Invest. 82:1988;1685-1693.
47. Sara V.R., Carlsson-Skwirut C., Drakenberg K., Giacobini M.B., Hakansson L., Mirmiran M., Nordberg A., Olson L., Reinecke M., Stahlbom P.A., Nordqvist A.C.S. The biological role of truncated insulin-like growth factor-I and the tripeptide GPE in the central nervous system. Ann. NY Acad. Sci. 692:1993;183-191.
48. Sell C., Baserga R., Rubin R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55:1995;303-306.
49. Singleton J.R., Randolph A.E., Feldman E.L. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res. 56:1996;4522-4529.
50. Sjoberg J., Kanje M. Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res. 485:1989;102-108.
51. Stenvers K.L., Lund P.K., Gallagher M. Increased expression of type I insulin-like factor receptor messenger RNA in rat hippocampal formation is associated with aging and behavioral impairment. Neuroscience. 72:1996;505-518.
52. Su J.H., Anderson A.J., Cummings B.J., Cotman C.W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533.
53. Tham A., Nordberg A., Grission F.E., Carlsson-Skwirut C., Viitanen M., Sara V.R. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer's type. J. Neural Transm. 5:1993;165-176.
54. Vijayan V.K., Geddes J.W., Anderson K.J., Chang-Chui H., Ellis W.G., Cotman C.W. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp. Neurol. 112:1991;72-78.
55. Yamaguchi F., Itano T., Miyamoto O., Janjua N.A., Ohmoto T., Hosokawa K., Hatase O. Increase in extracellular insulin-like growth factor 1 (IGF-1) concentration following electrolytical lesion in rat hippocampus. Neurosci. Lett. 128:1991;273-276.
56. Younkin S.G. Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37:1995;287-288.
57. Zhu C.Z., Auer R.N. Intraventricular administration of insulin and IGF-1 in transcient forebrain ischemia. J. Cereb. Blood Flow Metab. 14:1994;237-242.